SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-049990
Filing Date
2020-11-03
Accepted
2020-11-03 16:00:58
Documents
73
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sbph-10q_20200930.htm   iXBRL 10-Q 2240905
2 EX-10.6 sbph-ex106_408.htm EX-10.6 23873
3 EX-10.7 sbph-ex107_409.htm EX-10.7 20567
4 EX-31.1 sbph-ex311_7.htm EX-31.1 23514
5 EX-31.2 sbph-ex312_8.htm EX-31.2 22994
6 EX-32.1 sbph-ex321_6.htm EX-32.1 16097
  Complete submission text file 0001564590-20-049990.txt   8916739

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA sbph-20200930.xsd EX-101.SCH 53813
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sbph-20200930_cal.xml EX-101.CAL 49275
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sbph-20200930_def.xml EX-101.DEF 200608
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sbph-20200930_lab.xml EX-101.LAB 447978
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sbph-20200930_pre.xml EX-101.PRE 360022
12 EXTRACTED XBRL INSTANCE DOCUMENT sbph-10q_20200930_htm.xml XML 1808412
Mailing Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748
Business Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37718 | Film No.: 201283446
SIC: 2834 Pharmaceutical Preparations